Wiley Blackwell

SHERPA: Unknown

People

  1. Schoder
    Schoder
  2. Zelenetz
    Zelenetz
  3. Kumar
    Kumar
  4. Moskowitz
    Moskowitz
  5. Yahalom
    Yahalom
  6. Hamlin
    Hamlin
  7. Noy
    Noy
  8. Palomba
    Palomba
  9. Horwitz
    Horwitz
  10. Lewis
    Lewis

Groups

  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)
  7. Hematologic Malignancies, Division of (22)
  8. Sloan Kettering Institute Postdocs (21)
  9. Center for Hematologic Malignancies (20)
  10. Body Imaging Service (19)
Search Within
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (27)
  3. Review (8)
  4. Conference Paper (5)
  5. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)

More Groups

People
  1. Steven Larson (25)
  2. Heiko Schoder (22)
  3. Ronald Finn (10)
  4. Andrew Zelenetz (8)
  5. David Straus (8)
  6. Alison Moskowitz (7)

More People

Years
  1. 2024 (7)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (7)

More Years

Publications
  1. Cancer (18)
  2. Journal of Labelled Compounds and Radiopharmaceuticals (14)
  3. Hematological Oncology (13)
  4. Journal of Magnetic Resonance Imaging (10)
  5. Journal of Surgical Oncology (5)
  6. Breast Journal (3)

More Publications

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ROS-activatable prodrug of doxazolidine as novel cancer therapy paradigm
    Journal Article

    Tamura, R.; Carpenter, C. I.; Thomas, C. M.; Kamyabi, G.; Hsu, H. T.; Vergnolle, O.; Balderes, P.; Grimm, J.
    Advanced Therapeutics (2024)

    Fulltext@MSK | Save
  • Detection of GRM1 gene rearrangements in chondromyxoid fibroma: A comparison of fluorescence in-situ hybridisation, RNA sequencing and immunohistochemical analysis
    Journal Article

    Torrence, D.; Dermawan, J. K.; Zhang, Y.; Vanderbilt, C.; Hwang, S.; Mullaney, K.; Jungbluth, A.; Rao, M.; Gao, K.; Sukhadia, P.; more...
    Histopathology (2024)

    Fulltext@MSK | Save
  • Radial sclerosing lesions found on core needle biopsy: Excision can be safely avoided
    Journal Article

    Grabenstetter, A.; Brennan, S. B.; Jochelson, M. S.; Brogi, E.; Morrow, M.; Tan, L. K.; D'Alfonso, T. M.
    Histopathology (2024)

    Fulltext@MSK | Save
  • Update in the management of gastroenteropancreatic neuroendocrine tumors
    Review

    Sedlack, A. J. H.; Varghese, D. G.; Naimian, A.; Yazdian Anari, P.; Bodei, L.; Hallet, J.; Riechelmann, R. P.; Halfdanarson, T.; Capdevilla, J.; Del Rivero, J.
    Cancer (2024)

    Fulltext@MSK | Save
  • Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force
    Journal Article

    Koumarianou, A.; Filosso, P. L.; Bodei, L.; Castano, J. P.; Fernandez-Cuesta, L.; Deroose, C. M.; Foll, M.; Dromain, C.; Reed, N. S.; Caplin, M.; more...
    Journal of Neuroendocrinology (2024)

    Fulltext@MSK | Save
  • Small molecule-drug conjugates: Opportunities for the development of targeted anticancer drugs
    Review

    Zhang, J.; Hu, F.; Aras, O.; Chai, Y.; An, F.
    ChemMedChem (2024)

    Fulltext@MSK | Save
  • A survey of publicly available MRI datasets for potential use in artificial intelligence research
    Review

    Dishner, K. A.; McRae-Posani, B.; Bhowmik, A.; Jochelson, M. S.; Holodny, A.; Pinker, K.; Eskreis-Winkler, S.; Stember, J. N.
    Journal of Magnetic Resonance Imaging (2024)

    Fulltext@MSK | Save
  • GSH-activated porphyrin sonosensitizer prodrug for fluorescence imaging-guided cancer sonodynamic therapy
    Journal Article

    Deng, C.; Zheng, M.; Han, S.; Wang, Y.; Xin, J.; Aras, O.; Cheng, L.; An, F.
    Advanced Functional Materials (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save